EPHB2 and metastatic malignant neoplasm in the lymph nodes: Batlle et al. [31] detected the expression of EphB2 receptor in normal crypt stem cells, intestinal adenomas, in situ intestinal carcinoma, lymph node metastasis of intestinal cancer and hepatic metastasis, and found that the expression of EphB2 was decreased.